World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
48
Citations
6944
World Ranking
4457
National Ranking
2017

David W. Pascual publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David W. Pascual sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 201 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David W. Pascual D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David W. Pascual sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 48 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David W. Pascual is affiliated with the University of Florida in the United States and has contributed extensively to the fields of immunology and microbiology. Their research spans immunology, small animal studies, molecular biology, epidemiology, and infectious diseases, with a particular focus on immune responses and pathogen interactions.

The scientist's work covers a variety of main topics, including:

  • Brucella: diagnosis, epidemiology, treatment
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • Burkholderia infections and melioidosis
  • Immune Cell Function and Interaction
  • Galectins and Cancer Biology
  • Extracellular vesicles in disease

David W. Pascual has been involved in producing several papers, some of the recent ones include:

  • Antigen-encapsulating host extracellular vesicles derived from Salmonella-infected cells stimulate pathogen-specific Th1-type responses in vivo, 2021, published in PLoS Pathogens
  • Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection, 2020, published in PLoS Pathogens
  • Extracellular vesicles elicit protective immune responses against Salmonella infection, 2022, published in Journal of Extracellular Vesicles
  • Activation of mucosal immunity as a novel therapeutic strategy for combating brucellosis, 2022, published in Frontiers in Microbiology
  • Oral therapy with colonization factor antigen I prevents development of type 1 diabetes in Non-obese Diabetic mice, 2020, published in Scientific Reports

Frequent collaborators include:

  • Carol Hoffman
  • Xinghong Yang
  • Zakia I. Goodwin
  • Ali Akgül
  • Ella Bhagyaraj

Their research has been disseminated across various publication venues. Notable among these are:

  • The Journal of Immunology
  • PLoS Pathogens
  • Scientific Reports
  • Frontiers in Immunology
  • American Journal of Veterinary Research

In addition to journal articles, David W. Pascual has been involved in book publications, including a title published by Academic Press:

  • Mucosal vaccines: innovation for preventing infectious diseases, published in 2020

The collective output reflects a multidisciplinary approach integrating immunology, microbiology, and translational medical research to study infectious diseases and immune mechanisms, particularly focusing on pathogens like Brucella and Salmonella and the development of immune-based therapies and vaccines.

Best Publications

  • Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella.

    J L VanCott;H F Staats;D W Pascual;M Roberts

  • IL-35 Stimulation of CD39+ Regulatory T Cells Confers Protection against Collagen II-Induced Arthritis via the Production of IL-10

    Irina Kochetkova;Sarah Golden;Kathryn Holderness;Gayle Callis

  • Regulation of host immune responses by modification of Salmonella virulence genes.

    John L. VanCott;Stephen N. Chatfield;Mark Roberts;David M. Hone

  • Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS.

    K. L. Bost;S. A. L. Breeding;D. W. Pascual

  • Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide.

    D W Pascual;K L Bost

  • Progress in Brucella vaccine development

    Xinghong Yang;Jerod A. Skyberg;Ling Cao;Beata Clapp

  • M cell-targeted DNA vaccination

    Yunpeng Wu;Xinhai Wang;Keri L. Csencsits;Asmahan Haddad

  • Nasal-Associated Lymphoid Tissue: Phenotypic and Functional Evidence for the Primary Role of Peripheral Node Addressin in Naive Lymphocyte Adhesion to High Endothelial Venules in a Mucosal Site

    Keri L. Csencsits;Mark A. Jutila;David W. Pascual

  • Intratracheal Gene Delivery with Adenoviral Vector Induces Elevated Systemic IgG and Mucosal IgA Antibodies to Adenovirus and β-Galactosidase

    Frederik W. van Ginkel;Chongguang Liu;Jerry W. Simecka;Jian-Yun Dong

  • Antibodies against a peptide sequence within the HIV envelope protein crossreacts with human interleukin-2.

    Kenneth L. Bost;David W. Pascual

  • Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector.

    Jian-Yun Dong;Danher Wang;Frederik W. van Ginkel;David W. Pascual

  • Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge.

    Xinghong Yang;Todd Becker;Nancy Walters;David W. Pascual

  • Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production.

    D. W. Pascual;Jiangchun Xu-Amano;H. Kiyono;J. R. Mcghee

  • Substance P: a late-acting B lymphocyte differentiation cofactor.

    K. L. Bost;D. W. Pascual

  • Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing MAPK-AP-1 Pathway

    Xiaojin Sha;Shu Meng;Xinyuan Li;Hang Xi

  • Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.

    Elisa Burgos;Diego Gómez-Nicola;David Pascual;María Isabel Martín

  • Oral Immunization with a Salmonella typhimurium Vaccine Vector Expressing Recombinant Enterotoxigenic Escherichia coli K99 Fimbriae Elicits Elevated Antibody Titers for Protective Immunity

    Miguel A. Ascón;David M. Hone;Nancy Walters;David W. Pascual

  • Identification and characterization of a novel class of c-Jun N-terminal kinase inhibitors.

    Igor A. Schepetkin;Liliya N. Kirpotina;Andrei I. Khlebnikov;Tracey S. Hanks

  • Selection of Protective Epitopes for Brucella melitensis by DNA Vaccination

    Xinghong Yang;Mary Hudson;Nancy Walters;Robert F. Bargatze

  • Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response

    David W. Pascual;David M. Hone;Stacy Hall;Frederik W. van Ginkel

Frequent Co-Authors

Hiroshi Kiyono
Hiroshi Kiyono University of Tokyo
Kenneth L. Bost
Kenneth L. Bost University of North Carolina at Charlotte
Jerry R. McGhee
Jerry R. McGhee University of Alabama at Birmingham
Mark A. Jutila
Mark A. Jutila Montana State University
Herman F. Staats
Herman F. Staats Duke University
Kohtaro Fujihashi
Kohtaro Fujihashi University of Alabama at Birmingham
Soman N. Abraham
Soman N. Abraham Duke University
Sallie R. Permar
Sallie R. Permar Duke University
Shunji Kozaki
Shunji Kozaki Osaka Metropolitan University
Suzanne Oparil
Suzanne Oparil University of Alabama at Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Many pursue accelerated programs to start their careers faster. For example, 12-month accelerated nursing programs offer a streamlined path to becoming a registered nurse, which complements immunological knowledge in clinical settings.

Those seeking quicker certification options might consider the fastest and easiest LPN programs. These programs provide foundational nursing skills and can be stepping stones to advanced immunology-related roles in healthcare.

For advanced practice nurses, easy nurse practitioner programs to get into can be an attractive choice. Such programs prepare professionals for specialized clinical roles, many of which involve immunological patient care and research.

Additionally, mental health nursing intersects with immunology in caring for patient well-being. Highly regarded pmhnp programs online with best clinical placement ensure strong practical experience, crucial for those focusing on immunological impacts on mental health conditions.

Best Scientists Citing David W. Pascual

Trending Scientists